0001209191-23-022150.txt : 20230403 0001209191-23-022150.hdr.sgml : 20230403 20230403160543 ACCESSION NUMBER: 0001209191-23-022150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230330 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SEIDENBERG BETH C CENTRAL INDEX KEY: 0001184592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 23792615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-30 0 0001831828 Vera Therapeutics, Inc. VERA 0001184592 SEIDENBERG BETH C C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 1 0 0 0 0 Class A Common Stock 2023-03-30 4 P 0 2300 7.2395 A 1949295 I See Footnote The shares were purchased as follows: 2,224 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 76 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein. Represents weighted average purchase price. The shares were purchased at prices ranging from $7.23 to $7.25. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Consists of 1,884,776 shares of Class A Common Stock held by KPCB XVI and 64,519 shares of Class A Common Stock held by XVI Founders. /s/ Joseph R. Young, Attorney-in-Fact 2023-04-03